Skip to main content
SpringerLink
Log in

Schizophrenia and psychostimulant abuse: a review and re-analysis of clinical evidence

  • Review
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

The authors selected articles from those published between 1975 and 1994 that specifically documented psychostimulant abuse in patients determined to be schizophrenic according to recent and relatively uniform diagnostic criteria. These articles indicated that the incidence of psychostimulant abuse in schizophrenics is 2–5 times higher than that of the general public. Additionally, unlike the decline in stimulant use seen in older adults in the general population, high rates of abuse appeared to be maintained in schizophrenics. Although the incidence of abuse in this group was high, comparisons of abuse rates generated by self-report with those obtained by urinalysis indicated that the frequency of abuse is being underestimated by 15–21%. Potential factors contributing to stimulant abuse in schizophrenics, including the disease process, and the influence of chronic neuroleptic medication, were evaluated. Results indicated that the incidence of psychostimulant abuse was neither a common property of psychiatric patients, nor exclusive to schizophrenics, but appeared to be related to chronic treatment with neuroleptic drugs. Symptom severity was generally similar in schizophrenic abusers and non-abusers, which also suggested a degree of independence from the disease process. In a majority of the studies surveyed, abuse of stimulants followed disease onset. It was also found that stimulant abuse was associated with marked increases in hospitalization in this patient group, including those known to be neuroleptic medication compliant. Possible explanations for the initiation and maintenance of psychostimulant abuse in schizophrenics are discussed in relation to clinical and preclinical evidence on drug addiction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • American Medical Association (1991) Drug Evaluations Annual. AMA, Milwaukee, pp 238–267

    Google Scholar 

  • American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. American Psychiatric Association, Washington, D.C.

    Google Scholar 

  • Andreasen NC (1990) Positive and negative symptoms: historical and conceptual aspects. Mod Probl Pharmacopsychiatry 24:1–42

    Google Scholar 

  • Angrist BM, Gershon S (1970) The phenomenology of experimentally induced amphetamine psychosis-preliminary observations. Biol Psychiatry 2:95–107

    PubMed  Google Scholar 

  • Arndt S, Tyrrell G, Flaum M, Andreasen N (1992) Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment. Psychol Med 22:379–388

    PubMed  Google Scholar 

  • Bagshaw RJ, Shaw LM, August T, Young ML, Conahan TJ (1993) Unregulated self-medication in an ambulatory surgery population. Aviat Space Environ Med 64:324–326

    PubMed  Google Scholar 

  • Baldessarini RJ (1990) Drugs and the treatment of psychiatric disorders. In Goodman Gillman A, Rall T, Nies A, Taylor P (eds) Goodman and Gillman's the pharmacological basis of therapeutics. Pergamon Press, New York, pp 383–435

    Google Scholar 

  • Barbee JG, Clark PD, Crapanzano MS, Heintz GC, Kehoe CE (1989) Alcohol and substance abuse among schizophrenic patients presenting to an emergency psychiatric service. J Nerv Ment 177:400–407

    PubMed  Google Scholar 

  • Bell DS (1965) Comparison of amphetamine psychosis and schizophrenia. Br J Psychiatry 111:701–707

    PubMed  Google Scholar 

  • Bergman HC, Harris M (1985) Substance abuse among young adult chronic patients. Psychosocial Rehabil J 9:49–54

    Google Scholar 

  • Bhattacharyya A, Aulakh C, Pradhan S, Ghosh P, Pradhan S (1979) Modification of behavioral and neurochemical effects of cocaine by haloperidol. Arch In Pharmacology 238:71–80

    Google Scholar 

  • Brady K, Anton R, Ballenger JC, Lydiard RB, Adinoff B, Selander J (1990) Cocaine abuse among schizophrenic patients. Am J Psychiatry 147:1164–1167

    PubMed  Google Scholar 

  • Brady K, Casto S, Lydiard R, Malcolm R, Arana G (1991) Substance abuse in an inpatient psychiatric sample. Am J Drug Alcohol Abuse 17:389–397

    PubMed  Google Scholar 

  • Breakey WR, Goodell H (1972) Thought disorder in mania and schizophrenia evaluated by Bannister's grid test for schizophrenic thought disorder. Br J Psychiatry 120:391–395

    PubMed  Google Scholar 

  • Breakey WR, Goodell H, Lorenz PC, McHugh PR (1974) Hallucinogenic drugs as precipitants of schizophrenia. Psychol Med 4:255–261

    PubMed  Google Scholar 

  • Brockington I (1986) Diagnosis of schizophrenia and schizoaffective psychoses. In Bradley PB, Hirsch SR (eds) The psychopharmacology and treatment of schizophrenia. Oxford University Press, Oxford, pp 166–199

    Google Scholar 

  • Bunt G, Galanter M, Lifshutz H, Castaneda R (1990) Cocaine/”Crack” dependence among psychiatric inpatients Am J Psychiatry 147:1542–1546

    PubMed  Google Scholar 

  • Burke WM, Ravi NV, Dhopesh V, Vandigrift B, Maany I (1990) Prolonged presence of metabolite in urine after compulsive cocaine use J Clin Psychiatry 51:145–148

    PubMed  Google Scholar 

  • Carlsson A (1978) Mechanism of action of neuroleptic drugs. In Lipton MA, DiMascio A, Killian KF (eds) Psychopharmacology: a generation in progress. Raven Press, New York, pp 1057–1070

    Google Scholar 

  • Christie KA, Burke JD, Reiger DA, Rae DS, Boyd JH, Locke BZ (1988) Epidemiological evidence for early onset of mental disorders and high risk of drug abuse in young adults. Am J Psychiatry 145:971–975

    PubMed  Google Scholar 

  • Cleghorn JM, Kaplan RD, Szechtman B, Szechtman H, Brown GM. Franco S (1991) Substance abuse and schizophrenia: Effects on symptoms but not on neurocognitive function. J Clin Psychiatry 52:26–30

    Google Scholar 

  • Connell PH (1958) Amphetamine Psychosis. Oxford University Press, New York

    Google Scholar 

  • Creese I, Iversen SD (1975) The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Res 83:419–436

    Article  PubMed  Google Scholar 

  • Csernansky JG, Bellows EP, Barnes DE, Lombrozo L (1990) Sensitization to the dopamine turnover-elevating effects of haloperidol: the effect of regular/intermittent dosing. Psychopharmocology 101:19–524

    Article  Google Scholar 

  • Cuffel BJ (1992) Prevalence estimates of substance abuse in schizophrenia and their correlates. J Nerv Ment 180:589–592

    PubMed  Google Scholar 

  • Davidson ES, Finch JF, Schenk, S (1993) Variability in subjective responses to cocaine: Initial experiences of college students. Addict Behav 18:445–453

    Article  PubMed  Google Scholar 

  • Davis JM (1975) Overview maintenance therapy in psychiatry. I: schizophrenia. Am J Psychiatry 132:1237–1245

    PubMed  Google Scholar 

  • Davis JM, Kane JM, Marder SR, Brauzer B, Gierl B, Schooler N, Casey DE, Hassan M (1993) Dose response of prophylactic antipsychotics. J Clin Psychiatry (Suppl) 54:24–30

    Google Scholar 

  • De Wit H, Wise RA (1977) Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blockers phentolamine and phenoxbenzamine. Can J Psychol 31:195–203

    PubMed  Google Scholar 

  • De Wit H, Uhlenhuth EH, Johanson CE (1986) Individual differences in the reinforcing and subjective effects of amphetamine and diazepam. Drug Alcohol Depend 16:341–360

    Article  PubMed  Google Scholar 

  • Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Notl Acad Sci USA 85:5274–5278

    Google Scholar 

  • Dixon L, Haas G, Weiden P, Sweeney J (1990) Acute effects of drug abuse in schizophrenic patients: clinical observations and patients' self-reports. Schizophr Bull 16:69–79

    PubMed  Google Scholar 

  • Dixon L, Haas G, Weiden P, Sweeney J, Frances AJ (1991) Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am J Psychiatry 148:224–230

    PubMed  Google Scholar 

  • Elangovan N, Berman S, Meinzer A, Gianelli P, Miller H, Longmore W (1993) Substance abuse among patients presenting to an inner-city psychiatric emergency room. Hosp Commun Psychiatry 44:782–784

    Google Scholar 

  • Ellinwood EH, Kilbey MM (1977) Chronic stimulant intoxication models of psychosis. In: Hanin I, Usdin E (eds) Animal models in psychiatry and neurology. Pergamon Press, New York, pp 61–74

    Google Scholar 

  • Estroff TW, Gold MS (1985) Medical and psychiatric complications of cocaine abuse with possible points of pharmacological treatment. Adv Alcohol Subst Abuse 5:61–76

    PubMed  Google Scholar 

  • Fenton WS, McGlashan TH (1991) Natural history of schizophrenia subtypes II. Positive and negative symptoms and longterm course. Arch Gen Psychiatry 48:978–986

    PubMed  Google Scholar 

  • Ferguson GA, Takane Y (1989) Statistical analysis in psychology and education. McGraw-Hill, New York

    Google Scholar 

  • Fischman MW (1989) Relationship between self-reported drug effects and their reinforcing effects: Studies with stimulant drugs. NIDA Res Monogr 92:211–230

    PubMed  Google Scholar 

  • Fishman MW, Schuster CR, Krasnegor NA (1977) Physiological and behavioral effects of intravenous cocaine in man. In: Ellinwood EH, Kilbey MM (eds) Cocaine and other stimulants (advances in behavioral biology, vol 21). Plenum Press, New York, pp 647–664

    Google Scholar 

  • Foltz, RL, Fentiman, AF, Foltz, RB (1980) GC/MS assays for abused drugs in body fluids. NIDA Res Monogr 32

  • Galanter M, Castaneda R, Ferman J (1988) Substance abuse among general psychiatric patients: place of presentation, diagnosis and treatment. Am J Drug Alcohol Abuse 142:211–235

    Google Scholar 

  • Galanter M, Egelko S, De Leon G, Rohrs C, Franco H (1992) Crack/Cocaine abusers in the general hospital: assessment and initiation of care. Am J Psychiatry 149:810–815

    PubMed  Google Scholar 

  • Gawin FH (1986) Neuroleptic reduction of cocaine-induced paranoia but not euphoria? Psychopharmacology 90:142–143

    Article  PubMed  Google Scholar 

  • Gawin FH, Kleber HD (1986) Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Arch Gen Psychiatry 43:107–113

    PubMed  Google Scholar 

  • Goeders NE, Smith JE (1983) Cortical dopaminergic involvement in cocaine reinforcement. Science 221:773–774

    PubMed  Google Scholar 

  • Gold MS, Bowers MB (1978) Neurobiological vulnerability to lowdose amphetamine psychosis. Am J Psychiatry 135:1546–1548

    PubMed  Google Scholar 

  • Gottesman I (1991) Schizophrenia genesis: the origins of madness. W.H. Freeman and Company, New York

    Google Scholar 

  • Griffith JD, Cavanaugh J, Held J, Oates JA (1972) Dextroamphetamine: evaluation of psychomimmetic properties in man. Arch Gen Psychiatry 26:97–100

    PubMed  Google Scholar 

  • Groves PN, Rebec GV (1976) Biochemistry and behavior: some central actions of amphetamine and antipsychotic drugs. Ann R Psych 27:91–127

    Article  Google Scholar 

  • Hall RC, Popkin MK, Stickney SK, Gardner ER (1978) Covert outpatient drug abuse: incidence and therapist recognition. J Nerv Ment 166:343–348

    Google Scholar 

  • Hansell N, Willis GL (1977) Outpatient treatment of schizophrenia. Am J Psychiatry 134:1082–1086

    PubMed  Google Scholar 

  • Hansen HJ, Caudill SP, Boone J (1985) Crisis in drug testing: Results of a CDC blind study. JAMA 253:2382–2387

    Article  PubMed  Google Scholar 

  • Harrell AV (1985) Validation of self-report:the research record. NIDA Res Monogr 57:12–21

    PubMed  Google Scholar 

  • Hawks RL (1986) Analytical methodology. NIDA Res Monogr 73:30–42

    PubMed  Google Scholar 

  • Hegarty AM, Lipton RB, Merriam AE, Freeman K (1991) Cocaine as a risk factor for acute dystonic reactions. Neurology 41:1670–1672

    PubMed  Google Scholar 

  • Howell LL, Byrd LD (1992) Enhanced sensitivity to the behavioral effects of cocaine after chronic administrtaion of D2-selective sopamine antagonists in the squirrel monkey. J Pharmacol Exp Ther 262:907–915

    PubMed  Google Scholar 

  • Janowsky DS, Davis JM (1976) Methylphenidate, dextroamphetamine, and levamphetamine: effects on schizophrenic symptoms. Arch Gen Psychiatry 33:304–308

    PubMed  Google Scholar 

  • Janowsky DS, El-Yousef MK, Davis JM, Sekerke J (1973) Provocation of schizophrenic symptoms by intravenous administration of methylphenidate. Arch Gen Psychiatry 28:185–191

    PubMed  Google Scholar 

  • Johnston LD, O'Malley PM, Bachman JG (1993) National survey results on drug use from the monitoring the future study, 1975–1992, volume II. National Institute on Drug Abuse, Rockville, MD, NIH Publication No. 93-3598

    Google Scholar 

  • Johnston LD, O'Malley PM, Bachman JG (1994) National survey results on drug use from the monitoring the future study, 1975–1993, volume II. National Institute on Drug Abuse, Rockville, MD, NIH Publication No. 94-3810

    Google Scholar 

  • Katz JL (1989) Drugs as reinforcers: pharmacological and behavioral factors. In: Liebman JM, Cooper, SJ (eds) The neuropharmacological basis of reward. Oxford University Press, Oxford, pp 164–213

    Google Scholar 

  • Kety S (1981) Neurochemical and genetic basis of psychopathology: current status. Behav Genet 12:93–100

    Article  Google Scholar 

  • Kety S (1983) Mental illness in the biological and adoptive relatives of schizophrenic adoptees: findings relevant to genetic and environmental factors in etiology. Am J Psychiatry 140:720–727

    PubMed  Google Scholar 

  • Khantzian EJ (1985) The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry 142:1259–1264

    PubMed  Google Scholar 

  • Kivlahan DR, Heiman JR, Wright RC, Mundt JW, Shupe JA (1991) Treatment cost and rehospitalization rate in schizophrenic outpatients with a history of substance abuse. Hosp Commun Psychiatry 42:609–614

    Google Scholar 

  • Koob GF, Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242:715–723

    PubMed  Google Scholar 

  • Kuczenski R (1983) Biochemical Actions of Amphetamine and Other Stimulants. In Creese I (ed) Stimulants: neurochemical, behavioral, and clinical perspectives. Raven Press, New York, pp 31–61

    Google Scholar 

  • Kuczenski R, Segal DS, Aizenstein ML (1991) Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics. J Neurosci 11:2703–2712

    PubMed  Google Scholar 

  • Lawson WB (1994) Movement disorders in schizophrenic substance abusers. Biol Psychiatry 35:731

    Google Scholar 

  • LeDuc PA, Mittleman G (1993) Interactions between chronic haloperidol treatment and cocaine in rats: an animal model of intermittent cocaine use in neuroleptic treated populations. Psychopharmacology 110:427–436

    Article  PubMed  Google Scholar 

  • LeDuc PA, Mittleman G (1995) The effects of chronic haloperidol and intermittent cocaine administration on behavior elicited by apomorphine. Exp Clin Psychopharmacol 3:15–25

    Article  Google Scholar 

  • Lett BT (1989) Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine and cocaine. Psychophar 98:357–362

    Article  Google Scholar 

  • Lieberman JA, Kane JM, Alvir J (1987) Provocative tests with psychostimulant drugs in schizophrenia. Psychophar 91:415–433

    Article  PubMed  Google Scholar 

  • Louilot A, Buda M, Gonon F, Simon H, Le Moal M, Pujol JF (1985) Effect of haloperidol and sulpiride on dopamine metabolism in nucleus accumbens and olfactory tubercle: a study by in vivo voltammetry. Neuroscience 14:775–82

    Article  PubMed  Google Scholar 

  • Lysaker P, Bell M, Beam-Goulet J, Milstein R (1994) Relationship of positive and negative symptoms to cocaine abuse in schizophrenia. J Nerv Ment 182:109–112

    Google Scholar 

  • McLellan AT, Druley KA (1977) Non-random relation between drugs of abuse and psychiatric diagnosis. J Psychiatr Res 13:179–184

    Article  PubMed  Google Scholar 

  • McNagny SE, Parker RM (1992) High prevalence of recent cocaine use and the unreliability of patient self-report in an inner city walk-in clinic. JAMA 267:1106–1108

    Article  PubMed  Google Scholar 

  • Mesulam MM (1986) Cocaine and Tourette's syndrome. N Eng J Med 315:398

    Google Scholar 

  • Mieczkowski T (1990) The accuracy of self-reported drug use: an evaluation and analysis of new data. In: Weisheit R (ed) Drugs, crime and the criminal justice system. Anderson Publishing Co, Cincinnati, pp 275–302

    Google Scholar 

  • Mieczkowski T, Newel R (1993) An evaluation of patterns of racial bias in hair assays for cocaine: black and white arrestees compared. Forens Sci Int 63:85–98

    Article  Google Scholar 

  • Mieczkowski T, Barzelay D, Gropper B, Wish E (1991) Concordance of three measures of cocaine use in an arrestee population: hair, urine, and self-report. J Psychoact Drugs 23:241–249

    Google Scholar 

  • Miller FT, Tanenbaum JH (1989) Drug abuse in schizophrenia. Hosp Commun Psychiatry 40:847–849

    Google Scholar 

  • Mueser KT, Yarnold PR, Levinson DF, Singh H, Bellack AS, Kee K, Morrison RL, Yadalam KG (1990) Prevalence of substance abuse in schizophrenia: Demographic and clinical correlates. Schizophr Bull 16:31–56

    PubMed  Google Scholar 

  • Mueser KT, Yarnold PR, Bellack AS (1992) Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder. Acta Psychiatr Scand, 85:48–55

    PubMed  Google Scholar 

  • National Institute on Drug Abuse (1991) National household survey on drug abuse: main findings 1990. National Institute on Drug Abuse, Rockville, md. DHHS Publication No. (ADM) 91-1788

    Google Scholar 

  • O'Brien CP, Ehrman RN, Ternes JN (1986) Classical conditioning in human opioid dependence. In: Goldberg SR, Stolerman IP (eds) Behavioral analysis of drug dependence. Academic Press, London, pp 329–356

    Google Scholar 

  • Osterloh J (1993) Testing for drugs of abuse: Pharmacokinetic considerations for cocaine in urine. Clin Pharmacokinet 24:355–361

    PubMed  Google Scholar 

  • Pettit HO, Justice JB (1989) Dopamine in the nucleus accumbens during cocaine self-administration as studied by in vivo microdialysis. Pharmacol Biochem Behav 34:899–904

    Article  PubMed  Google Scholar 

  • Piazza PV, Deminiere JM, Le Moal M, Simon H (1989) Factors that predict individual vulnerability to amphetamine self-administration. Science 245:1511–1513

    PubMed  Google Scholar 

  • Picker D (1988) Perspectives on a time-dependent model of neuroleptic action. Schizophr Bull 14:255–268

    PubMed  Google Scholar 

  • Post RM (1981) Central stimulants: clinical and experimental evidence on tolerance and sensitization. In: Israel Y, Glaser FB, Kalant H, Popham RE, Schmidt W, Smart RG (eds) Research advances in alcohol and drug problems, vol. 6. Plenum Press, New York, pp 1–65

    Google Scholar 

  • Pulvirenti L, Swerdlow NR, Hubner CB, Koob GF (1991) The role of limbic-accumbens-pallidal circuitry in the activating and reinforcing properties of psychostimulant drugs. In: Willner P, Scheel-Kruger J (eds) The mesolimbic dopamine system: from motivation to action. Wiley, New York, pp 131–140

    Google Scholar 

  • Randrup A, Munkvad I, Usden P (1963) Adrenergic mechanisms and amphetamine induced abnormal behavior. Acta Pharmacol Toxicol 20:145–157

    Google Scholar 

  • Rastogi SK, Rastogi RB, Singhal RL, Lapierre YD (1983) Behavioural and biochemical alterations following haloperidol treatment withdrawal: the animal model reexamined. Prog Neuropsychopharmacol 7:153–164

    Article  Google Scholar 

  • Resnick RB, Kestenbaum RS, Schwartz LK (1977) Acute systemic effects of cocaine in man: a controlled study by intranasal and intravenous routes. Science 195:696–698

    PubMed  Google Scholar 

  • Richard ML, Liskow BI, Perry PJ (1985) Recent psychostimulant use in hospitalized schizophrenics. J Clin Psychiatry 46:79–83

    PubMed  Google Scholar 

  • Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237:1219–1223

    PubMed  Google Scholar 

  • Robinson TE, Becker JB (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaulation of animal models of amphetamine psychosis. Brain Res Rev 11:157–198

    Article  Google Scholar 

  • Robinson TE, Berridge KC (1993) The neural basis of drug craving: and incentive-sensitization theory of addiction. Brain Res Rev 18:247–291

    Article  PubMed  Google Scholar 

  • Rockwell DA, Ostwald P (1968) Amphetamine use and abuse in psychiatric patients. Arch Gen Psychiatry 18:612–616

    PubMed  Google Scholar 

  • Rosenthal RN, Hellerstein DJ, Miner CR (1994) Positive and negative syndrome typology in schizophrenic patients with psychoactive substance use disorders. Comp Psychiatry 35:91–98

    Article  Google Scholar 

  • Schneier FR, Siris SG (1987) A review of psychoactive substance use and abuse in schizophrenia: patterns of drug choice. J Nerv Ment 175:641–652

    Google Scholar 

  • Schnoll SH, Daghestani AN, Hansen TR (1984) Cocaine dependence. Resident Staff Physician 30:24–31

    Google Scholar 

  • Segal DS, Mandell AJ (1974) Long-term administration of Damphetamine: progressive augmentation of motor activity and stereotypy. Pharmacol Biochem B 2:249–255

    Article  PubMed  Google Scholar 

  • Seibyl JP, Satel SL, Anthony D, Southwick SM, Krystal JH, Charney DS (1993) Effects of cocaine on hospital course in schizophrenia. J Nerv Ment 181:31–37

    Google Scholar 

  • Sevy S, Kay SR, Opler LA, Praag HM (1990) Significance of cocaine history in schizophrenia. J Nerv Ment 178:642–648

    Google Scholar 

  • Shaner A, Khalsa ME, Roberts L, Wilkins J, Anglin D, Hsieh SC (1993) Unrecognized cocaine use among schizophrenic patients. Am J Psychiatry 150:758–762

    PubMed  Google Scholar 

  • Siris SG, Kane JM, Frechen K, Sellew AP, Mandeli J, Fasano-Dube B (1988) Histories of substance abuse in patients with postpsychotic depressions. Compr Psychiatry 29:550–557

    Article  PubMed  Google Scholar 

  • Spitzer RL (1980) Introduction. In: American Psychiatric Association: diagnostic and statistical manual of mental disorders, 3rd Edn. APA, Washington D.C., pp 1–12

    Google Scholar 

  • Stone AM, Greenstein RA, Gamble G, McLellan AT (1993) Cocaine use by schizophrenic outpatients who receive depot neuroleptic medication. Hosp Commun Psychiatry 44:176–177

    Google Scholar 

  • Swerdlow NR, Vaccarino FJ, Amalric M, Koob GF (1986) The neural substrate for the motor-activating properties of psychostimulants: a review of recent findings. Pharmacol Biochem Behav 25:233–248

    Google Scholar 

  • Test MA, Wallisch LS, Allness DJ, Ripp K (1989) Substance use in young adults with schizophrenic disorders. Schizophr Bull 15:465–476

    PubMed  Google Scholar 

  • Weiss RD, Gawin FH (1988) Protracted elimination of cocaine metabolites in long-term high-dose abusers. Am J Med 85:879–880

    PubMed  Google Scholar 

  • Weiss RD, Mirin SM, Michael JL, Sollogub AC (1986) Psychopathology in chronic cocaine abusers. Am J Drug Alcohol Abuse 12:17–29

    PubMed  Google Scholar 

  • White FJ, Wang RY (1983) Comparison of the effects of chronic haloperidol treatment on A9 and A10 dopamine neurons in the rat. Life Sci 32:983–993

    Article  PubMed  Google Scholar 

  • Wilkins JN, Shaner AL, Patterson CM, Setoda, D, Gorelick D (1991) Discrepancies between patient report, clinical assessment, and urine analysis in psychiatric patients during inpatient admission. Psychopharmacol Bull 27:149–154

    PubMed  Google Scholar 

  • Wilmot CA, Szczepanik AM (1989) Effects of acute treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain. Brain Res 487:288–298

    Article  PubMed  Google Scholar 

  • Wise RA (1982) Neuroleptics and operant behavior: The anhedonia hypothesis. Behav Brain Sci 5:39–88

    Google Scholar 

  • Wise RA (1984) Neural mechanisms of the reinforcing action of cocaine. NIDA Res Monogr 50:5–33

    Google Scholar 

  • Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94:469–492

    Article  PubMed  Google Scholar 

  • Witkin JM (1994) Pharmacotherapy of cocaine abuse: preclinical development. Neurosci Biobehav Rev 18:121–142

    Article  PubMed  Google Scholar 

  • Wolpe PR, Gorton G, Serota R, Sanford B (1993) Predicting compliance of dual diagnosis inpatients with aftercare treatment. Hosp Commun Psychiatry 44:45–49

    Google Scholar 

  • Woolverton WL, Virus RM (1989) The effects of a D1 and a D2 dopamine antagonist on behavior maintained by cocaine or food. Biochem Behav 32: 691–697

    Article  Google Scholar 

  • Woolverton WL, Cervo L, Johanson CE (1984) Effects of repeated methamphetamine administration on methamphetamine self-administration in rhesus monkeys. Pharmacol Biochem Behav 21:737–741

    PubMed  Google Scholar 

  • Wysowski DK, Baum C (1989) Antipsychotic drug use in the United States, 1976–1985. Arch Gen Psychiatry 46:929–932

    PubMed  Google Scholar 

  • Yesavage J, Zarcone V (1983) History of drug abuse and dangerous behavior in inpatient schizophrenics. J Clin Psychiatry 44:259–261

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Psychology Department, The University of Memphis, 38152, Memphis, IN, USA

    P. A. LeDuc & G. Mittleman

Authors
  1. P. A. LeDuc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Mittleman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

LeDuc, P.A., Mittleman, G. Schizophrenia and psychostimulant abuse: a review and re-analysis of clinical evidence. Psychopharmacology 121, 407–427 (1995). https://doi.org/10.1007/BF02246489

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02246489

Key words

Search

Navigation